Medicaid margin expected to decline at least 125 bps in 2026
Reported gross margin was 24.79%, reinforcing the quarter's better-than-guided profitability.
Elevance Health reported Q3 2025 adjusted EPS of $6.03, in line with expectations, and reaffirmed full-year EPS of approximately $30. Management provided a cautious 2026 planning outlook, notably guiding for at least a 125 bps decline in Medicaid margins, while also planning several hundred million in strategic investments. The call focused on Medicaid headwinds, Medicare positioning, ACA subsidy uncertainty, and progress in Carillon (pharmacy/services) and AI partnerships. Medicaid operating margin expected to be ~negative 50 bps in 2025 and decline at least 125 bps in 2026 due to elevated acuity and rate lags.
Elevance Health reported Q3 2025 adjusted EPS of $6.03, in line with expectations, and reaffirmed full-year EPS of approximately $30. Management provided a cautious 2026 planning outlook, notably guiding for at least a 125 bps decline in Medicaid margins, while also planning several hundred million in strategic investments. The call focused on Medicaid headwinds, Medicare positioning, ACA subsidy uncertainty, and progress in Carillon (pharmacy/services) and AI partnerships. Medicaid operating margin expected to be ~negative 50 bps in 2025 and decline at least 125 bps in 2026 due to elevated acuity and rate lags.
Reported gross margin was 24.79%, reinforcing the quarter's better-than-guided profitability.
Guidance tone
Guidance tone
Management discussed several hundred million dollars of incremental investments in 2026, primarily focused on technology adoption (AI, core systems), expanding Carelon capabilities, and operational/quality initiatives like improving star ratings. These are front-loaded…
Management emphasized AI as a strategic enabler, deploying AI and digital tools to enhance member experience, reduce provider burden, and drive efficiency. They highlighted significant adoption, with more than 10 million members having access to their AI-enabled virtual assistant, and noted partnerships like OpenAI to train associates. These investments are positioned to improve operating leverage
Management reaffirms 2025 EPS but warns of Medicaid margin deterioration and investment spending in 2026, creating a cautious near-term outlook.
Management discussed several hundred million dollars of incremental investments in 2026, primarily focused on technology adoption (AI, core systems), expanding Carelon capabilities, and operational/quality initiatives like improving star ratings. These are front-loaded investments aimed at driving long-term operating leverage and future growth.
Management acknowledged challenging dynamics in Medicaid and ACA, provided prudent planning assumptions for 2026, and emphasized discipline and focus, while maintaining confidence in long-term strategy.
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| EPS | FY2025 | $30.00 | $30.00 | MAINTAINED |
1 of 1 · 평균 편향 +1.0%
Elevance Health is partnering with OpenAI to train employees on AI tools, reflecting a focus on AI adoption across operations.
“We just signed a partnership with OpenAI where we're going to actually train our folks to be able to use these skills appropriately.”
Hi, thanks. I just wanted to ask about, you know, some of the investment spending that you flagged in the slides. I think, you know, you're talking about potentially several hundred million dollars of investment. Obviously, the company's investing, you know, every year. So, trying to understand what you guys are trying to spike there in terms of materiality to 2026. And then it also, you know, you look at some of the commentary that you have on 2027 and speaking about, you know, the influence of investment spending on your ability to grow earnings there. Is it fair to think that some of this increased investment is transitory in nature? Just hoping we can understand that better coming off…
… our outcomes, and also the experience from members, providers, and associates. And maybe just to put some real tangible examples on that, I shared a little bit in my opening comments. For members, for example, our personalized match feature in our Sydney helps one in five of our members right now select the right provider using more than 500 personalized data points and improving that navigation and satisfaction. We're using it across our customer service. We have tools that improve our first contact resolution, shorten wrap-up time, help with proactive engagement. And I think really importantly for the commitments we've made on care providers, our HealthOS platform is automating our onboarding, our contracting, our roster management. It's also reducing a lack of information so that we have reduced denials by more than 68% and peer-to-peer reviews by over 100%, so we're getting real-time data. That's also giving us greater insight into some of the things that Felicia shared, which is how we get ahead of the cost curve. So across the enterprise, we see it as a huge opportunity. to help support our productivity goals. We look at it to reduce the burdens on care providers by reducing our chart request by almost half. And then our national account teams, for example, are using it to update benefits and onboard clients. So across the board, including for our own associates, we're investing in them as well. We just signed a partnership with OpenAI where we're going to actually train our folks to be able to use these skills appropriately. The reason I wanted to share more detail on that is we're embedding these at scale across our operations and prioritizing high-use impact cases that reduce, first, the complexity. They drive savings and enhance the experience, which are two of our core goals. One, reducing the cost curve, and two, enhancing the experience our members have. So what we see is this is going to create leverage for us, improve affordability, strengthen operational performance, and support sustainable long-term growth. And to your last question around sort of the impact of those, we see these as front-loaded investments across the board. Mark shared that. We're seeing great pickup in the investments we've made in STARS. I just shared the AI investments, and we think that they help support us. So thank you for that question, and next question, please.